Facebook
Twitter
Telegram
Report an ErrorCorcept Therapeutics Incorporated Cash Flow 2011-2024 | CORT
Annual Cash Flow Corcept Therapeutics Incorporated
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
127 M | 120 M | 168 M | 152 M | 136 M | 116 M | 60.9 M | 18.4 M | - | - | -37.1 M | -36 M | -27.4 M |
Depreciation & Amortization |
577 K | 782 K | 1.07 M | 525 K | 703 K | 236 K | 106 K | 87 K | 155 K | 141 K | 74 K | 27 K | 3 K |
Accounts Payables |
17.4 M | 12 M | 6.91 M | 10.6 M | 7.54 M | 8.27 M | 8.58 M | 2.29 M | 1.32 M | 1.89 M | 2.38 M | 3.8 M | 3.61 M |
Accounts Receivables |
41.1 M | 31.1 M | 27.6 M | 26.2 M | 19.9 M | 17.6 M | 15.3 M | 9.86 M | 6.22 M | 3.33 M | 1.43 M | 557 K | - |
Total Inventories |
7.73 M | 6.1 M | 4.99 M | 4.91 M | 5.42 M | 4.73 M | 4.58 M | 2.33 M | 1.68 M | 1.21 M | 1.1 M | 853 K | - |
All numbers in USD currency
Quarterly Cash Flow Corcept Therapeutics Incorporated
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
23.8 M | - | - | 26 M | - | 86.9 M | - | 35.2 M | - | 118 M | - | 25.4 M | - | 117 M | 86.5 M | 33.3 M | - | 87.7 M | 49.2 M | 23.7 M | - | 94.1 M | 49.6 M | 34.4 M | - | 36.1 M | 25.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -11.6 M | - | -27.3 M | -18 M | -10.2 M | - | -21.1 M | -14.5 M | -7.3 M |
Depreciation & Amortization |
68 K | - | - | 172 K | - | 599 K | - | 288 K | - | 783 K | - | 254 K | - | 447 K | 362 K | 238 K | - | 474 K | 263 K | 96 K | - | 163 K | 105 K | 48 K | - | 58 K | 22 K | 13 K | - | 72 K | 51 K | 27 K | - | 127 K | 97 K | 40 K | - | 104 K | 65 K | 28 K | - | 53 K | 33 K | 14 K | - | 14 K | 8 K | 3 K | - | 1 K | 1 K | - |
Accounts Payables |
12.6 M | 16.7 M | 7.98 M | 11.2 M | - | 8.18 M | - | 9.27 M | 6.91 M | 6.56 M | 9.22 M | 6.97 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 7.54 M | 7.54 M | 7.54 M | 7.54 M | 8.27 M | 8.27 M | 8.27 M | 8.27 M | 8.58 M | 8.58 M | 8.58 M | 8.58 M | 2.29 M | 2.29 M | 2.29 M | 2.29 M | 1.32 M | 1.32 M | 1.32 M | 1.32 M | 1.89 M | 1.89 M | 1.89 M | 1.89 M | 2.38 M | 2.38 M | 2.38 M | 2.38 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.61 M | 3.61 M | 3.61 M | 3.61 M |
Accounts Receivables |
61.5 M | 34.6 M | 32.6 M | 32.6 M | - | 29.4 M | - | 27.2 M | 27.6 M | 26.5 M | 27.6 M | 22.2 M | 26.2 M | 26.2 M | 26.2 M | 26.2 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | 9.86 M | 9.86 M | 9.86 M | 9.86 M | 6.22 M | 6.22 M | 6.22 M | 6.22 M | 3.33 M | 3.33 M | 3.33 M | 3.33 M | 1.43 M | 1.43 M | 1.43 M | 1.43 M | 557 K | 557 K | 557 K | 557 K | - | - | - | - |
Total Inventories |
7.19 M | 7.51 M | 6.92 M | 6.41 M | - | 6.05 M | - | 5.08 M | 4.99 M | 4.99 M | 4.67 M | 4.95 M | 4.91 M | 4.91 M | 4.91 M | 4.91 M | 5.42 M | 5.42 M | 5.42 M | 5.42 M | 4.73 M | 4.73 M | 4.73 M | 4.73 M | 4.58 M | 4.58 M | 4.58 M | 4.58 M | 2.33 M | 2.33 M | 2.33 M | 2.33 M | 1.68 M | 1.68 M | 1.68 M | 1.68 M | 1.21 M | 1.21 M | 1.21 M | 1.21 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 853 K | 853 K | 853 K | 853 K | - | - | - | - |
All numbers in USD currency